These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24380698)

  • 1. Role of defensins in the pathogenesis of chronic lung allograft rejection.
    Tiriveedhi V; Banan B; Deepti S; Nataraju A; Hachem R; Trulock E; Alexander PG; Thalachallour M
    Hum Immunol; 2014 Apr; 75(4):370-7. PubMed ID: 24380698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation.
    Saini D; Angaswamy N; Tiriveedhi V; Fukami N; Ramachandran S; Hachem R; Trulock E; Meyers B; Patterson A; Mohanakumar T
    J Heart Lung Transplant; 2010 Dec; 29(12):1330-6. PubMed ID: 20691611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
    Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
    J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome.
    Anderson RL; Hiemstra PS; Ward C; Forrest IA; Murphy D; Proud D; Lordan J; Corris PA; Fisher AJ
    Eur Respir J; 2008 Sep; 32(3):670-7. PubMed ID: 18508823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
    Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
    Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation.
    Zheng L; Walters EH; Ward C; Wang N; Orsida B; Whitford H; Williams TJ; Kotsimbos T; Snell GI
    Thorax; 2000 Jan; 55(1):53-9. PubMed ID: 10607802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BALF cytokines in different phenotypes of chronic lung allograft dysfunction in lung transplant patients.
    Berastegui C; Gómez-Ollés S; Sánchez-Vidaurre S; Culebras M; Monforte V; López-Meseguer M; Bravo C; Ramon MA; Romero L; Sole J; Cruz MJ; Román A
    Clin Transplant; 2017 Mar; 31(3):. PubMed ID: 28008659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation.
    Ross DJ; Cole AM; Yoshioka D; Park AK; Belperio JA; Laks H; Strieter RM; Lynch JP; Kubak B; Ardehali A; Ganz T
    Transplantation; 2004 Oct; 78(8):1222-4. PubMed ID: 15502724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation.
    Itabashi Y; Ravichandran R; Bansal S; Bharat A; Hachem R; Bremner R; Smith M; Mohanakumar T
    Transplantation; 2021 Jun; 105(6):1337-1346. PubMed ID: 32890135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection.
    Nelsestuen GL; Martinez MB; Hertz MI; Savik K; Wendt CH
    Proteomics; 2005 Apr; 5(6):1705-13. PubMed ID: 15800973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential cytokine, chemokine and growth factor expression in phenotypes of chronic lung allograft dysfunction.
    Verleden SE; Ruttens D; Vos R; Vandermeulen E; Moelants E; Mortier A; Van Raemdonck DE; Proost P; Schols D; Verleden GM; Vanaudenaerde BM
    Transplantation; 2015 Jan; 99(1):86-93. PubMed ID: 25050473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients.
    Belperio JA; DiGiovine B; Keane MP; Burdick MD; Ying Xue Y; Ross DJ; Lynch JP; Kunkel SL; Strieter RM
    Transplantation; 2002 Feb; 73(4):591-9. PubMed ID: 11889437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic differences between phenotypes of chronic lung allograft dysfunction after lung transplantation.
    Suwara MI; Vanaudenaerde BM; Verleden SE; Vos R; Green NJ; Ward C; Borthwick LA; Vandermeulen E; Lordan J; Van Raemdonck DE; Corris PA; Verleden GM; Fisher AJ
    Transpl Int; 2014 Aug; 27(8):857-67. PubMed ID: 24750386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.
    Takenaka M; Subramanian V; Tiriveedhi V; Phelan D; Hachem R; Trulock E; Gelman AE; Patterson GA; Hoshinaga K; Mohanakumar T
    J Heart Lung Transplant; 2012 Nov; 31(11):1214-22. PubMed ID: 22980951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.
    Belperio JA; Keane MP; Burdick MD; Lynch JP; Xue YY; Berlin A; Ross DJ; Kunkel SL; Charo IF; Strieter RM
    J Clin Invest; 2001 Aug; 108(4):547-56. PubMed ID: 11518728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
    Magnusson JM; Ericson P; Tengvall S; Stockfelt M; Brundin B; Lindén A; Riise GC
    Respir Res; 2022 May; 23(1):108. PubMed ID: 35501858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection.
    Bharat A; Narayanan K; Street T; Fields RC; Steward N; Aloush A; Meyers B; Schuessler R; Trulock EP; Patterson GA; Mohanakumar T
    Transplantation; 2007 Jan; 83(2):150-8. PubMed ID: 17264811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration.
    Reynaud-Gaubert M; Marin V; Thirion X; Farnarier C; Thomas P; Badier M; Bongrand P; Giudicelli R; Fuentes P
    J Heart Lung Transplant; 2002 Jul; 21(7):721-30. PubMed ID: 12100898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.